The assessment will focus on the risk of resistant zoonotic bacteria spreading among poultry, pigs and cattle during transport to other farms or to slaughterhouses. When antimicrobial resistance (AMR) occurs in zoonotic bacteria – bacteria that can be passed from animals to humans – it can also compromise the effective treatment of infectious diseases in humans. EFSA will also review preventive measures and control options, and identify data needs to support further analysis of the issue. The final scientific opinion is expected to be finalised by September 2022.

Further information: Antimicrobial resistance: What is the risk of spread through animal transport? | EFSA (europa.eu)

The news was shared by the EFSA Focal Point, run by Nébih and EFSA.